BPI-3016
- Generic Name
- BPI-3016
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- 50AL13JD55
- Background
BPI-3016 is under investigation in clinical trial NCT03188848 (Dose Escalating Study of BPI-3016 in Healthy Subjects).
- Associated Conditions
- -
- Associated Therapies
- -
Dose Escalating Study of BPI-3016 in Healthy Subjects
- First Posted Date
- 2017-06-15
- Last Posted Date
- 2019-01-02
- Lead Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 63
- Registration Number
- NCT03188848
- Locations
- 🇨🇳
Beijing Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath